Ann Leen, PhD, from Baylor College of Medicine, Houston, TX, US, provides an overview of the ‘off the shelf’ use of virus-specific T cell therapy. At the moment, the therapy targets 5 viruses but the aim is to include more viruses over time.
Recorded at the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Valencia, Spain.